Magnetic Resonance Imaging
Volume 24, Issue 5 , Pages 603-609 , June 2006

Magnetic resonance imaging of microvascular leakage induced by myocardial contrast echocardiography in rats

Received 16 September 2005 ,Accepted 3 December 2005.

References 

  1. Mulvagh SL, DeMaria AN, Feinstein SB, Burns PN, Kaul S, Miller JG, et al. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr. 2000;13:331–342
  2. In:  Goldberg BB,  Raichlen JS,  Forsberg F editor. Ultrasound contrast agents. 2nd ed.. London: Martin Dunitz Ltd.; 2001;
  3. Nyborg WL, Carson PL, Carstensen EL, Dunn F, Miller DL, Miller MW, et al. Exposure criteria for medical diagnostic ultrasound: II. Criteria based on all known mechanisms. Report No. 140. Bethesda (Md): National Council on Radiation Protection and Measurements; 2002;
  4. Fowlkes JB, Holland CK. Mechanical bioeffects from diagnostic ultrasound: AIUM consensus statements. American Institute of Ultrasound in Medicine. J Ultrasound Med. 2000;19:67–168
  5. Miller DL. The safety of ultrasound contrast agents. In:  ter Haar G,  Duck F editor. The safe use of ultrasound in medical diagnosis. London: The British Medical Ultrasound Society/The British Institute of Radiology; 2000;p. 72–85
  6. Miller DL, Pislaru SV, Greenleaf JE. Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somat Cell Mol Genet. 2002;27:115–134
  7. Lindner JR, Kaul S. Delivery of drugs with ultrasound. Echocardiography. 2001;18:329–337
  8. Mizushige K, Kondo I, Ohmori K, Hirao K, Matsuo H. Enhancement of ultrasound-accelerated thrombolysis by echo contrast agents: dependence on microbubble structure. Ultrasound Med Biol. 1999;25:1431–1437
  9. Song J, Qi M, Kaul S, Price RJ. Stimulation of arteriogenesis in skeletal muscle by microbubble destruction with ultrasound. Circulation. 2002;106:1550–1555
  10. Miller DL, Li P, Gordon D, Armstrong WF. Histological characterization of micro-lesions induced by myocardial contrast echocardiography. Echocardiography. 2005;22:25–34
  11. Skyba DM, Price RJ, Linka AZ, Skalak TC, Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation. 1998;98:290–293
  12. Price RJ, Skyba DM, Kaul S, Skalak TC. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation. 1998;98:1264–1267
  13. Miller DL, Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci U S A. 2000;97:10179–10184
  14. Li P, Cao LQ, Dou CY, Armstrong WF, Miller DL. Impact of myocardial contrast echocardiography on vascular permeability: an in vivo dose response study of delivery mode, ultrasound power and contrast dose. Ultrasound Med Biol. 2003;29:1341–1349
  15. Song J, Chappell JC, Qi M, VanGieson EJ, Kaul S, Price RJ. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol. 2002;39:726–731
  16. Miller DL, Li P, Armstrong WF. The effect of time and of vasoactive drugs on capillary leakage induced during myocardial contrast echocardiography. Echocardiography. 2004;21:125–132
  17. Unger EC, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev. 2004;56:1291–1314
  18. Floris S, Blezer EL, Schreibelt G, Dopp E, van der Pol SM, Schadee-Eestermans IL, et al. Blood–brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain. 2004;127(Pt 3):616–627
  19. Ford JC, Wood AK, Van Winkle TJ, Kundel HL. Magnetic resonance imaging observations of blood–brain-barrier permeability in an animal model of brain injury. Acad Radiol. 1997;4:115–126
  20. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–59
  21. Saeed M, van Dijke CF, Mann JS, Wendland MF, Rosenau W, Higgins CB, et al. Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction. J Magn Reson Imaging. 1998;8:561–567
  22. Schwitter J, Saeed M, Wendland MF, Derugin N, Canet E, Brasch RC, et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol. 1997;30:1086–1094
  23. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Non-invasive opening of BBB by focused ultrasound. Acta Neurochir Suppl. 2003;86:555–558
  24. Hynynen K, McDannold N, Martin H, Jolesz FA, Vykhodtseva N. The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison). Ultrasound Med Biol. 2003;29:473–481

PII: S0730-725X(05)00407-8

doi: 10.1016/j.mri.2005.12.014

Magnetic Resonance Imaging
Volume 24, Issue 5 , Pages 603-609 , June 2006